MARC Record from Library of Congress

LEADER: 02867cam a22004218a 4500
001 2007008964
003 DLC
005 20070326080104.0
008 070302s2007 nyu b 001 0 eng
035 $a(DNLM)101300739
010 $a 2007008964
020 $a9780824729455 (hb : alk. paper)
020 $a0824729455 (hb : alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRS201.E87$bO7377 2007
060 10 $aW1$bDR893B v.170 2007
060 10 $aQV 38$bO635 2007
082 00 $a615/.1$222
245 00 $aOral lipid-based formulations :$benhancing the bioavailability of poorly water-soluable drugs /$c[edited by] David J. Hauss.
260 $aNew York, NY :$bInforma Healthcare USA,$cc2007.
263 $a0706
300 $ap. ;$ccm.
440 0 $aDrugs and the pharmaceutical sciences ;$vv. 170
504 $aIncludes bibliographical references and index.
505 0 $aCurrently marketed oral lipid-based dosage forms : drug products and excipients / Robert Strickley -- Feasibility assessment for scaling bench-top prototype lipid-based formulations to initial phase I/II clinical trial batches / Paul Sirois -- Lipid-based excipients for oral drug delivery / Lowell Gibson -- Process and manufacturing considerations and final characterization of oral lipid-based formulations / Bill Bowtie -- Liquid self-micro-emulsifying drug delivery systems (SMEDDS) / Annette Mullertz -- Lipid based isotropic solutions : design considerations / Navnit Shah -- Lipid-based self-emulsifying solid dispersions / Abu Serajuddin -- Preclinical in vivo evaluation of oral lipid-based formulations / Chris Porter, Bill Charman -- Physiological processes governing the gastrointestinal absorption of lipids and lipophilic xenobiotics / Patrick Tso -- Characterizing release from lipid-based formulations / Jennifer Dressman -- Using in vitro dynamic lipolysis modeling as a tool for exploring IVIVC relationships for oral lipid-based formulations / Annette Mullertz -- Case study: rational development of self-emulsifying formulations for improving the oral bioavailability of poorly soluble, lipophilic drugs / Ping Gao -- Design and development of supersaturatable SEDDS (S-SEDDS) formulations for enhancing the gastrointestinal absorption of poorly soluble drugs / Ping Gao.
650 0 $aLipids$xTherapeutic use.
650 0 $aDrugs$xSolubility.
650 0 $aSolutions (Pharmacy)
650 0 $aDrugs$xDosage forms.
650 12 $aBiological Availability.
650 12 $aSolubility$xdrug effects.
650 22 $aDosage Forms.
650 22 $aDrug Administration Routes.
650 22 $aDrug Delivery Systems$xmethods.
700 1 $aHauss, David J.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0712/2007008964.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0709/2007008964-d.html